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Mercury is prevalent in the environment as a
result of both natural processes and emissions
from anthropogenic sources (Keating et al.
1997; Wiener et al. 2003). However, atmos-
pheric deposition from anthropogenic emis-
sions such as coal power plants is frequently
the major source of Hg in aquatic systems
(Landis and Keeler 2002). After deposition,
inorganic Hg is methylated by microbes,
then biomagnified in aquatic food webs.
Subsequently, the greatest concentrations of
methylmercury (MeHg) are found in piscivo-
rous ﬁsh and wildlife (Spry and Wiener 1991;
Watras and Bloom 1992). MeHg is the most
toxic form of Hg, and nearly all (95–99%)
Hg in fish is MeHg (Bloom 1992; Grieb
et al. 1990).
The environmental risks associated with
MeHg have been explored mainly in relation-
ship to the risks to human health associated
with consumption of contaminated ﬁsh. The
main route of MeHg exposure in humans is
through ﬁsh consumption, and the body bur-
den of MeHg in humans is directly correlated
to the quantities of ﬁsh consumed (Bjornberg
et al. 2005; Cole et al. 2004). Hg in its
methylated form is neurotoxic, particularly to
developing nervous systems, and has been
associated with many different neurological
problems, from learning disabilities and behav-
ioral changes to death (National Research
Council 2000; Zelikoff et al. 1995). However,
the mechanistic effects of MeHg on other
physiological processes such as reproduction
are relatively unknown, and there are compar-
atively few studies that examine risks of MeHg
exposure on fish populations themselves
(Armstrong 1979; Spry and Wiener 1991;
Wiener et al. 2003).
The few studies on the impact of MeHg
contamination on fish have shown conse-
quences for reproduction. For example, fat-
head minnows (FHM), Pimephales promelas,
fed MeHg-contaminated diets that simulated
concentrations found in zooplankton, inverte-
brates, and small fish in North America
showed a delay in spawning, a decline in
spawning activity, and a decline in the number
of eggs laid (Hammerschmidt et al. 2002) with
increasing MeHg. Dietary MeHg impairs
gonadal development in walleye (Sander
vitreus; Friedmann et al. 1996), FHM
(Hammerschmidt et al. 2002) and walking
catﬁsh (Clarias batrachus; Kirubagaran and Joy
1988, 1992) and causes testicular atrophy in
guppies (Wester 1991).
The mechanism by which MeHg alters
reproduction is unclear. However, there is
some indication that MeHg suppresses sex hor-
mones that elicit secondary sex characteristics
and stimulate gonadal development and game-
togenesis. In the companion study (Drevnick
and Sandheinrich 2003) to the present article,
exposure to environmentally relevant concen-
trations of MeHg inhibited gonadal develop-
ment and suppressed estrogen production in
female FHM and testosterone in male FHM.
Male ﬁsh fed a control diet had mean testos-
terone concentrations that were 20 and 116%
greater than those fed low-MeHg (0.87 µg/g
dry wt) and medium-MeHg (3.93 µg/g dry wt)
diets, respectively. Female ﬁsh fed a control diet
had mean estrogen concentrations that were
164 and 416% greater than those fed low- and
medium-MeHg diets. Other studies have
found similar results in ﬁsh at various concen-
trations (Arnold et al. 1998; Fynn-Aikins et al.
1998). MeHg also interferes with vitellogenesis
(Kirubagaran and Joy 1988) and spermato-
genesis (Kirubagaran and Joy 1992).
Genomic markers provide a useful tool to
examine the physiological mechanisms that
may be affected by toxicant exposure [for
review see Klaper and Thomas (2004)].
Genomic techniques allow simultaneous
measurement of multiple biochemical path-
ways at levels of sensitivity not available with
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BACKGROUND: Methylmercury (MeHg) is a known neurotoxic agent, but the mechanisms by which
MeHg may act on reproductive pathways are relatively unknown. Several studies have indicated
potential changes in hormone levels as well as declines in vertebrates with increasing dietary MeHg
exposure.
OBJECTIVES: The purpose of this study was to identify alterations in gene expression associated with
MeHg exposure, speciﬁcally those associated with previously observed changes in reproduction and
reproductive biomarkers. Fathead minnows, Pimephales promelas, were fed one of three diets that
were similar to documented concentrations of MeHg in the diets of wild invertivorous and piscivo-
rous fish. We used a commercial macroarray in conjunction with quantitative polymerase chain
reaction to examine gene expression in ﬁsh in relation to exposure to these environmentally relevant
doses of MeHg.
RESULTS: Expression of genes commonly associated with endocrine disruption was altered with Hg
exposure. Speciﬁcally, we observed a marked up-regulation in vitellogenin mRNA in individual Hg-
exposed males and a signiﬁcant decline in vitellogenin gene expression in female ﬁsh with increas-
ing Hg concentrations. Other genes identified by the macroarray experiment included those
associated with egg fertilization and development, sugar metabolism, apoptosis, and electron trans-
port. We also observed differences in expression patterns between male and female ﬁsh not related
to genes speciﬁcally associated with reproduction, indicating a potential physiological difference in
the reaction of males and females to MeHg. 
CONCLUSION: Gene expression data may provide insight into the mechanisms by which MeHg
affects reproduction in ﬁsh and indicate how MeHg differs in its effect from other heavy metals and
endocrine-disrupting compounds. 
KEY WORDS: endocrine disruption, gene expression, mercury, methylmercury, microarray, Pimephales
promelas, reproduction, toxicogenomics, vitellogenin. Environ Health Perspect 114:1337–1343
(2006). doi:10.1289/ehp.8786 available via http://dx.doi.org/ [Online 30 May 2006]other biomarkers. Moreover, they provide
information that cannot be obtained with
currently available tests such as traditional
ELISA assays (Klaper and Thomas 2004).
Recent evidence has demonstrated the util-
ity of genomic techniques in assessing the
effects of dietary MeHg on ﬁsh. Using real-time
quantitative polymerase chain reaction (qPCR),
Gonzalez et al. (2005) examined the expression
of 13 genes in muscle, liver, and brain tissue of
zebraﬁsh (Danio rerio). Dietary exposures of 5
and 13.5 µg MeHg/g dry wt increased expres-
sion of genes cytochrome c oxidase subunit I
(coxI) and cytoplasmic superoxide dismutase
(sod) associated with mitochondrial metabolism
and production of reactive oxygen species
(ROS) in liver and skeletal muscle. The speciﬁc
changes in gene expression in that study pro-
vide an indication of the potential mechanisms
by which MeHg may be affecting these tissues.
However, the study did not examine gene
expression in relation to a speciﬁc physiological
response and did not examine genes involved in
reproduction pathways, and exposures were
higher than normal environmental exposures.
In the research presented here we assessed
gene expression in FHM fed diets contaminated
with environmentally relevant concentrations
of MeHg as a continuation of the previous
study by Drevnick and Sandheinrich (2003)
that found altered reproduction associated with
increased MeHg exposure. We used a combi-
nation of genomic techniques, including a
commercial macroarray, a suppressive subtrac-
tion hybridization, and qPCR, to identify dif-
ferentially expressed genes associated with
MeHg exposure in the FHM. The goal of this
research was to begin to examine the mechanis-
tic relationship between reproductive changes
and gene expression and to identify potential
endocrine changes that may be linked to
MeHg exposure.
Materials and Methods
Test organisms. We obtained embryos of FHM
from the Upper Midwest Environmental
Sciences Center (U.S. Geological Survey, La
Crosse, WI) and raised them to maturity.
Before exposure, larvae were fed Artemia
nauplii for 60 days and then fed Sterling Silver
Cup Fish Food (Nelson and Sons Inc., Murray,
UT) for 30 days. Subsequently, 200 ﬁsh were
transferred to each of fifteen 180-L flow-
through aquaria for exposure studies. Aquaria
were filled with well water, temperature was
maintained at 23.6 ± 0.1°C, and each received
a 16/8-hr light/dark photoperiod cycle.
Additional information on the experimental
design and culturing of FHM can be found in
Drevnick and Sandheinrich (2003).
MeHg exposure treatments and RNA
extraction. Minnows were fed food containing
one of three concentrations of MeHg at 5%
body mass per day: control (0.058 ± 0.004 µg/g
dry wt), low MeHg (0.87 ± 0.02 µg/g dry wt),
or medium MeHg (3.93 ± 0.08 µg/g dry wt).
All three concentrations were designed to repre-
sent the diets of insectivorous and piscivorous
ﬁsh from some midcontinental low-alkalinity
lakes contaminated with Hg from non-point
sources (Hammerschmidt et al. 2002). Diets
were prepared by mixing food with methyl-
mercuric chloride in alcohol. Control diets were
mixed with alcohol alone. Alcohol was evapo-
rated from the food, and the diet was frozen
until use. Fish were fed their respective food
treatment for 600 days. Fish in this study were
used in accordance with protocols approved by
the University of Wisconsin–La Crosse
Institutional Animal Care and Use Committee.
Animals used were treated humanely and with
regard for the alleviation of suffering. After
600 days the fish were euthanized. The liver
was harvested, placed in 2 mL of Trizol reagent
(Invitrogen, Carlsbad, CA) and kept at –80°C
until extraction. RNA was extracted per manu-
facturer’s intructions for Trizol.
Macroarray construction and analysis.
The macroarray used in the experiment was a
commercially available 200-gene FHMinnow
array from EcoArray, Inc. (Alachua, FL;
http://www.ecoarray.com/). Arrays were con-
structed, hybridized, and analyzed at EcoArray
as previously described (Larkin et al. 2002,
2003). Arrays consisted of cDNA spotted in
duplicate onto 11.5 × 7.6-cm neutral nylon
membranes. Controls included water blanks,
Cot-1 repetitive sequences, M13 sequence, and
exogenous spiking genes from Arabidopsis
thaliana used for normalization purposes
(SpotReport 3; Stratagene, La Jolla, CA). Total
RNA was DNase treated (Ambion, Austin,
TX) and radiolabeled with (α-33P)dATP
(Strip-EZ RT; Ambion), and 0.6 ng of spiking
RNA was added to each labeling reaction.
After hybridization, we quantitatively evaluated
the arrays using a Typhoon 8600 imaging sys-
tem (Amersham Pharmacia Biotech, Molecular
Dynamics, Sunnyvale, CA).
Macroarray experimental design. We
exposed sixteen membranes for the macroarray
experiment. Four ﬁsh of each sex were chosen
from both the control and highest MeHg dose
treatment based on highest RNA quality as
determined by absorbance at 260/280 nm and
gel electrophoresis. Each sample was separately
exposed to array. For each cDNA clone repre-
sented on the membrane, we substracted the
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Table 1. Primers used for qPCR and RNA standards for qPCR.
Gene locusa Primer Primer sequence Product size (bp)
vtg cRNA FP TAATACGACTCACTATAGG
CATCAAGGAGAAGTTCCTGGCT 401
cRNA RP ATTTAGGTGACACTATAGAGGT
AGGAGCTTCATGATGGT 
apo cRNA FP TAATACGACTCACTATAGG
GCTTAGTTGAAGTAGTCAGTG 426
cRNA RP ATTTAGGTGACACTATAGC
CTGACAAGGAGTTAGTTGAGA
nasp cRNA FP TAATACGACTCACTATAGG
TCAGAGGATTCTTCTGGGACTC 363
cRNA RP ATTTAGGTGACACTATAGC
GAGGAAACAGCATCTGCTTCA
zp2 cRNA FP TAATACGACTCACTATAGGGTA
CACTTCCTACTACAGTG 372
cRNA RP ATTTAGGTGACACTATAGAGATG
GTTTCCTGCAGAGGAG
vtg FP TGACAGCTAGTTTGGCTATG 149
RP AATATCATGGATGGGCCTGA
apo FP CACTGGCCAGACCGCTGATAA 155
RP GAGGATTGTCACTGCTTGGGA
nasp FP CTTCTCAGCTAGCATGGCACAA 133
RP GCAGACAGCTCCGTCGATGTTA
zp2 FP GATGGATGCCCTTACCAGGATG 157
RP AGATGGTTTCCTGCAGAGGAG
Abbreviations: FP, forward primer; RP, reverse primer.
aPrimary sequences submitted to GenBank (http://www.ncbi.nih.gov/Genbank).
Recombinant cRNA standard (321–448 bp)
Real-time qPCR amplicon (133–192 bp)
T7 Target sequence Target FP Target FP Target sequence SP6
cRNA FP (~40 bp) cRNA RP (~40 bp)
Figure 1. Diagram demonstrating design of cRNA standards for qPCR.general background of each membrane from
the average value of the duplicate spots on the
membrane. The values were then normalized
to the average value of two spiking genes that
were spotted on the membranes. Data from
control and MeHg-treated ﬁsh were compared
with a t-test. Additional information about
genes found on the 200-gene FHMinnow
array is provided in the Supplemental Material
available online for this article (http://www.
ehponline.org/members/2006/8786/
supplemental.pdf).
qPCR analysis. qPCR was performed for
10 individuals from each treatment for a select
number of genes. Genes were selected by
cross-referencing differentially expressed genes
in the macroarray data with genes found in a
suppressive subtraction hybridization. Because
gene sequence is necessary to design primers
for qPCR, genes identified through suppres-
sive subtractions that also showed signiﬁcant
differential expression on macroarrays were
chosen for qPCR analysis. These included
FHM vitellogenin [vtg, GenBank accession no.
AF130354; http://www.ncbi.nih.gov)] and
zona pellucida 2 (zp2, GenBank accession no.
EB684274). In addition apolipoprotein (apo,
GenBank accession no. EB684272) and nuclear
autoantigenic sperm protein (nasp, GenBank
accession no. EB684273 ) were also identiﬁed
through suppressive subtraction and were cho-
sen because of their role in reproduction.
Primers for PCR were selected in areas of
intron/exon junctions (where possible) to mini-
mize the potential for DNA ampliﬁcation dur-
ing qPCR. To determine splice sites, each gene
sequence was aligned to zebrafish sequences
[ZFIN database (Zebrafish Information
Network; http://zfin.org)] using bl2seq
(Tatusova and Madden 1999] and compared
to intron–exon junctions on the ZFIN data-
base. Primers (Table 1) were chosen to amplify
approximately 150 bp of each target gene
and designed to have approximately similar
melting temperatures (52–58°C) and a gua-
nine and cytosine content of 40–60% with
minimal repeats. All primers were synthesized
and HPLC purified at Integrated DNA
Technologies (Coralville, IA).
Recombinant cRNA standards were used
for quantification using standard curves as
described (Rees and Li 2004; Vanden Heuvel
1998). Brieﬂy, cRNA standards for each of the
genes listed above ranged in size from 321 to
448 bp (Table 1). A cRNA PCR product con-
taining a 5´ T7 promoter, a region of target-
gene–speciﬁc sequence including the region of
the real-time amplicon, and an SP6 promoter
at the 3´ end (Figure 1) was created using
cDNA from a sample (GeneAmp RNA PCR
Kit; Applied Biosystems, Foster City, CA).
The cRNA product was reampliﬁed, cleaned
(QIAquick PCR Purification Kit; Qiagen,
Valencia, CA), and transcribed using the
Riboprobe In Vitro Transcription System
(Promega Corp., Madison, WI) according to
Gene expression changes with methylmercury exposure
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Table 2. Macroarray gene expression resultsa for female FHM exposed to MeHg-contaminated diets (3.93 ± 0.08 µg MeHg/g dry wt) versus control diets (0.058 ±
0.004 µg MeHg/g dry wt). 
aCommercial macroarray. Genes names are from GenBank (http://www.ncbi.nih.gov/GenBank) and the European Molecular Biology Laboratory of the European Bioinformatics Institute
(EMBL-EBI; http://www.ebi.ac.uk/embl/).
Gene name Fold change p-Value
vitellogenin 1 0.6 0.3113
vitellogenin precursor 0.6 0.4106
glyceraldehyde 3-phosphate dehydrogenase 1.7 0.0263
novel retinal pigment epithelial gene (NORPEG) 2.0 0.3606
piwi protein 2.0 0.5345
phosphoenolpyruvate carboxykinase 2.0 0.2376
heat shock protein 90-beta 2.0 0.2320
L-pipecolic acid oxidase 2.0 0.4516
actin 1 2.0 0.0689
heat shock protein Hsp70 2.0 0.5003
dual speciﬁcity phosphatase 13; protein phosphatase 2.0 0.4574
cytosolic branched-chain amino acid aminotransferase 2.0 0.4710
histone H1-0 2.0 0.4968
isocitrate dehydrogenase 2 (NADP+), mitochondrial 2.0 0.4458
G protein pathway suppressor 1; Arabimdopsis  2.1 0.1854
FUS6/COP11 homolog
X-box-binding protein 1B 2.1 0.4827
cathepsin D precursor 2.1 0.3563
von Willebrand factor-cleaving protease precursor 2.1 0.4257
pyruvate kinase 2.1 0.5065
A-kinase anchoring protein-associated sperm protein 2.1 0.4567
oxysterol binding protein-like 9 isoform a 2.1 0.2378
mannose binding-like lectin 2.1 0.4514
bile salt export pump 2.2 0.1110
transcription factor JUN-B 2.2 0.3334
glutathione S-transferase 1 (GST-CL1) (GST CLASS-THETA) 2.2 0.4336
ventricular myosin heavy chain 2.3 0.3905
acyl carrier protein, mitochondrial precursor (ACP) 2.3 0.4527
succinyl CoA:3-oxoacid CoA transferase 2.3 0.3305
cell surface glycoprotein HT7 precursor 2.3 0.2830
ubiquitin-like protein SMT3A 2.3 0.4100
protein serine threonine kinase Clk4 2.3 0.4232
cytosolic sulfotransferase 2.3 0.3929
spermatogenesis-preventing substance 2.4 0.3869
apolipoprotein Eb; apolipoprotein E 2.4 0.1711
gonadotropin-regulated long chain acyl-CoA synthetase 2.4 0.4122
GDP-mannose pyrophosphorylase B, isoform 2 2.4 0.4177
ribosomal protein P2 2.4 0.2349
acyl-coenzyme A dehydrogenase, C-4 to C-12 straight chain 2.4 0.3715
adenylate kinase 7 2.4 0.3979
stathmin 2.5 0.3786
Gene name Fold change p-Value
cytochrome P450 51 2.5 0.3985
heat shock protein HSP 90-alpha (HSP 86) 2.5 0.4709
acyl-CoA oxidase type 1 2.5 0.3990
ribophorin I 2.5 0.3879
matrix metalloproteinase 9 2.5 0.4384
guanosine monophosphate reductase 2.5 0.4486
beta-ureidopropionase 2.5 0.3735
transposon-derived Buster1 transposase-like protein 2.5 0.3560
creatine kinase, testis isozyme 2.6 0.2586
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) 2.6 0.4240
uridine-cytidine kinase 1 2.6 0.4133
CPEB-associated factor Maskin 2.6 0.3647
eukaryotic translation elongation factor 2; 2.6 0.2497
polypeptidyl-tRNA translocase
tubulin, alpha 3; tubulin alpha 3 2.6 0.2231
glutathione reductase 1 2.7 0.3697
zinc ﬁnger protein 151 (Zinc ﬁnger protein Z13) 2.7 0.3620
glucose-6-phosphate-1-dehydrogenase; G6PD 2.7 0.3684
glutamine synthetase 2.7 0.3560
alpha tubulin 2.7 0.2810
eukaryotic translation initiation factor 3, subunit 8 2.8 0.2724
signal peptidase 25 kDA subunit 2.8 0.2700
tubulin beta-1 chain 2.9 0.3540
ependymin precursor (EPD) 2.9 0.3219
S100 calcium-binding protein, beta (neural) 3.0 0.4088
carboxypeptidase B 3.0 0.3561
axonemal dynein heavy chain 7 3.0 0.3940
kainate receptor beta chain precursor 3.0 0.3571
fucosidase, alpha-L-1, tissue 3.1 0.3476
chloride intracellular channel 2 3.1 0.4201
thyroid hormone receptor associated protein complex  3.2 0.2888
TRAP230/KIAA0192
angiotensinogen precursor 3.3 0.2102
UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter 3.4 0.3009
androgen receptor 1 3.4 0.3362
ubiquitin-conjugating enzyme E2D 2 3.5 0.2676
cyclin A2 3.6 0.1748
asparaginase and ankyrin repeat family member 3.6 0.3353
scavenger receptor cysteine-rich type 1 protein M160 3.8 0.3507
ZP2 9.5 0.1554
ZP3 11.1 0.1349standard protocol. Each cRNA was DNase-
treated (Promega Corp.) with RQ1 RNase-free
DNase followed by phenol:chloroform extrac-
tion (24:1). The aqueous phase was isolated
and extracted with chloroform–isoamyl alcohol
(24:1) followed by an overnight ethanol
precipitation at –20°C. Each cRNA pellet was
resuspended in 20 µL RNase-free water
(Gibco, Invitrogen, Grand Island, NY) and
filtered through a NucAway Spin Column
(Ambion) to remove free nucleotides. The size
and quality of the cRNA standard were veriﬁed
by analysis on an agarose gel and quantiﬁed at
260 nm.
First-strand cDNA for samples was synthe-
sized using the GeneAmp RNA PCR kit
(Ambion). Reactions were incubated at room
temperature for 10 min; incubated for 30 min
at 42°C, 5 min at 99°C; then stored at –20°C
until used for template in PCR. Products were
quantiﬁed using Brilliant SYBR Green QPCR
(Stratagene) according to manufacturer’s direc-
tions and 300 nM of each primer. PCR reac-
tions were analyzed on an MJ Research DNA
Engine Opticon System (BioRad Laboratories,
Waltham, MA) under the following condi-
tions: 1 cycle of 95°C for 5 min, 40 cycles of
94°C for 30 sec, 56°C for 30 sec, 72°C for
1 min, and 1 cycle at 72°C for 10 min. The
cycle threshold [C(t)] was manually set at
0.005 for all plates. A melting curve was gener-
ated to check for presence of nonspeciﬁc PCR
products. Target gene samples were performed
in triplicate, and copy number was estimated
against a standard curve. Negative PCR con-
trols were used to check for genomic DNA
contamination, and all real time-reverse tran-
scriptase PCR products were run on agarose
gels. Treatments were compared using a
Kruskall-Wallis test as analyzed with SPSS
(version 13.0; SPSS, Inc., Chicago, IL).
Results
Detection of changes in gene expression using
macroarray. Dietary MeHg altered the expres-
sion of dozens of genes in liver tissue, including
those related to reproduction. Using the
EcoArray macroarray, we were able to identify
76 genes in female FHM and 42 in males that
were differentially expressed (2-fold difference)
between the highest-MeHg-exposed ﬁsh and
controls as determined by comparing the aver-
age for each sex over each treatment. However,
large variation in response among individual
ﬁsh and small sample size (n = 4 macroarrays
per sex, per treatment) resulted in a large num-
ber of statistically nonsignificant values
(Tables 2, 3).
Gene expression differed by sex, and the
effects of treatment on gene expression differed
by sex. Vitellogenin mRNA, a phosphoglycol-
ipoprotein associated with egg production and
normally produced solely in female fish,
increased an average 142.8-fold over controls
in male fish. Macroarrays were spotted with
multiples of this gene because it is of interest in
endocrine disruption studies (circled in
Figure 2B). Control male ﬁsh (Figure 2A) did
not express vitellogenin RNA, although several
treated males had large amounts of vitellogenin
RNA (Figure 2B). This result was highly vari-
able among treated males. In females, vitel-
logenin mRNA expression was down-regulated
0.6× on average in treated ﬁsh.
Expression of RNA coding for zona pellu-
cida proteins ZP2 and ZP3 also appeared to
Klaper et al.
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Table 3. Macroarray gene expressiona results male FHM exposed to MeHg-contaminated diets (3.93 ±
0.08 µg MeHg/g  dry wt) versus control diets (0.058 ± 0.004 µg MeHg/g dry wt). 
Gene name Fold change p-Value
phosphoethanolamine methyltransferase 0.2 0.0273
transcription factor JUN-B 0.3 0.3853
ﬁbronectin 1 0.3 0.1483
polyunsaturated fatty acid elongase 0.3 0.3617
serine-pyruvate aminotransferase 0.3 0.2567
fatty acid synthase 0.3 0.1857
glucose-6-phosphatase 0.4 0.0773
intestinal fatty acid binding protein 0.4 0.1941
L-threonine 3-dehydrogenase 0.4 0.3831
annexin VI 0.4 0.2342
superoxide dismutase 0.4 0.0870
transferrin variant D 0.4 0.2122
ubiquitin speciﬁc protease 15 0.4 0.2228
cytochrome P450 (2F2) 0.4 0.1455
25-hydroxyvitamin D3 24-hydroxylase 0.5 0.2357
gonadotropin-regulated long chain acyl-CoA synthetase 0.5 0.1703
antithrombin 0.5 0.1259
lanosterol synthase 0.5 0.5225
bile salt export pump 0.5 0.3028
3-hydroxy-3-methylglutaryl-Coenzyme A reductase 0.5 0.3053
cytochrome c oxidase subunit I 0.5 0.2533
4-hydroxyphenylpyruvate dioxygenase 1.9 0.0664
alpha amylase 1.9 0.0895
zinc ﬁnger protein 151 (zinc ﬁnger protein Z13) 2.0 0.2678
pyruvate kinase 2.0 0.3628
hepatic glucose transporter GLUT2 2.0 0.2632
retinol binding protein 4, plasma 2.0 0.0159
matrix metalloproteinase 9 2.2 0.2291
ventricular myosin heavy chain 2.3 0.2332
biliverdin reductase B [ﬂavin reductase (NADPH)] 2.3 0.4626
kinesin-like protein 2 2.4 0.3089
tubulin beta-1 chain 2.4 0.3005
eukaryotic translation initiation factor 3, subunit 8 2.5 0.1936
cyclin A2 2.5 0.2848
homogentisate 1, 2-dioxygenase 2.6 0.3151
tubulin, alpha 3; tubulin alpha 3 2.8 0.1727
zona pellucida 2 (ZP2) 2.8 0.4347
nucleoside phosphorylase 2.9 0.1578
protein serine threonine kinase Clk4 3.5 0.3601
zona pellucida 3 (ZP3) 14.7 0.3218
vitellogenin precursor 76.3 0.2971
vitellogenin 1 142.8 0.3292
aCommercial macroarray. Genes names from GenBank (http://www.ncbi.nih.gov/GenBank) and the European Molecular
Biology Laboratory of the European Bioinformatics Institute (EMBL-EBI; http://www.ebi.ac.uk/embl/).
A B
Figure 2. EcoArray macroarray of 200 genes exposed to cDNA from (A) a single control male ﬁsh and (B)a  ﬁ s h
exposed to a diet of 4 µg MeHg/g dry wt. Blue circles show location on the array where vitellogenin was spot-
ted in duplicate in the shape of an “E.” Vitellogenin mRNA was expressed to a greater extent in  the exposed
ﬁsh (B)  where the spots are clearly visible than in the control (A) where no spots are visible for vitellogenin.be up-regulated in individual male (2.8× and
14.7×, respectively) and female ﬁsh (9.5× and
11.1×, respectively), although the increase
was statistically nonsignificant. Genes that
were signiﬁcantly down-regulated and statisti-
cally significant in males included phospho-
ethanolamine methyltransferase (0.2× change
treated vs. control) and glucose 6-phosphatase
(0.4×). In males, retinal binding protein 4
increased 2-fold (p = 0.0159) and 4-hydroxy-
phenylpyruvate dioxygenase and α-amylase
were also up-regulated (1.9×), but the statisti-
cal significance was slightly > p = 0.05
(p = 0.0664 and p = 0.0895, respectively)
(Table 3). Genes putatively up-regulated in
females included glyceraldehyde 3-phosphate
dehydrogenase (gapdh) (1.7×, p = 0.0263).
Interestingly, gapdh is a common cellular
component and is considered to be expressed
constitutively; therefore it is often used as a
gene for normalization of qPCR data. It was
not used here because of its change with
exposure.
qPCR analysis of differential gene expres-
sion. qPCR supported the results of macroarray
experiments for vitellogenin, apolipoprotein,
and nasp, with differences only in the scale of
estimated up-regulation or down-regulation
and the signiﬁcance of the effect of treatment;
macroarrays underestimated effects compared
with qPCR results. MeHg-treated female ﬁsh
showed signiﬁcantly lower expression in vitel-
logenin RNA than in control ﬁsh (p = 0.004,
χ2 = 10.835, df = 2; Figure 3). Both MeHg
treatments down-regulated vitellogenin RNA
production to almost the same magnitude.
Using the macroarray, vitellogenin was down-
regulated approximately 2-fold; however,
qPCR estimated a 4-fold down-regulation in
female fish. The significance of changes in
female vitellogenin mRNA expression also
increased with qPCR measurements either due
to technique or to the inclusion of all of the
individuals from the experiment (n = 10 vs.
n = 4). From qPCR results, it appears that
genes approaching 1.7× over controls may also
be differentially regulated.
Dietary MeHg up-regulated expression of
the vitellogenin gene in livers of several of the
male ﬁsh in both MeHg treatments; none of
the male fish fed control diets expressed the
gene. However, there was signiﬁcant variabil-
ity in response in MeHg-fed males, with some
of the treated fish showing no up-regulation
and some with signiﬁcant up-regulation (rang-
ing from 0 to 200× over control males). This
contributed to the overall average increase in
expression and also to the lack of statistical sig-
nificance (Table 4). This was similar to the
ﬁndings of the macroarrays, where vitellogenin
RNA was up-regulated 142× with variation
among individuals leading to insigniﬁcant sta-
tistical measures across the group as a whole.
Dietary MeHg also altered expression of
apolipoprotein in females, causing an increase
in expression of approximately 4-fold in both
treatments (χ2 = 8.861, df = 2, p = 0.012) and
increased nasp by 20–40× (χ2 = 6.151, df = 2,
p = 0.046). Zona pellucida expression, also
commonly measured in association with
endocrine disruption, did not appear to vary
with exposure.
Discussion
In this study, we assessed gene expression in
FHM fed diets with up to 4 µg MeHg/g dry
wt—environmentally relevant concentrations
that have been shown previously to suppress
the production of sex hormones and alter
reproduction in minnows (Drevnick and
Sandheinrich 2003; Hammerschmidt et al.
2002). Many industrial chemicals have been
linked to the disruption of endocrine function
(Colborn et al. 1993), but research has focused
primarily on compounds that are similar in
structure to estrogens. It is possible that MeHg
may act as an endocrine disruptor by binding
to estrogen receptors and acting essentially as
an estrogen mimic. Cadmium, cobalt, nickel,
lead, and Hg have been shown to activate
estrogen receptors and increase their produc-
tion (Garcia-Morales et al. 2004; Henson and
Chedrese 2004; Johnson et al. 2003; Martin
et al. 2003; Stoica et al. 2000). However, there
are notable differences between genes differen-
tially expressed in this study and those identi-
fied in studies of other metals. Our data
indicate that MeHg may have a different mode
of action than other heavy metals, particularly
at environmentally relevant exposure levels for
MeHg. Studies have indicated that heavy met-
als may affect reproduction through interfer-
ence with estrogen-responsive elements
(Vetillard and Bailhache 2005) but invariably
cause changes in ROS, which may also be the
basis for changes in endocrine function with
other Hg species and other heavy metals
(Henson and Chedrese 2004; Martin et al.
2003). This is seen with cadmium, for exam-
ple, which affects vitellogenin protein produc-
tion but also induces sod and glutathione
S-transferase (gst) (Olsson et al. 1995; Pereira
et al. 1993; Sheader et al. 2006). We did not
find significant genomic changes associated
Gene expression changes with methylmercury exposure
Environmental Health Perspectives • VOLUME 114 | NUMBER 9 | September 2006 1341
Table 4. qPCR results for all FHM in all treatments measured as molecules per nanogram RNA for each gene product standardized to total RNA.
Average female Average male
Signiﬁcance Signiﬁcance
Gene locus Treatment Molecules/ng (± SE) (χ2, df, p-value) Molecules/ng (± SE) (χ2, df, p-value)
vtg Control 4.0 × 107 ± 4.8 × 106 χ2 = 9.374, df = 2, 6,756 ± 4,284 χ2 = 1.627, df = 2,
Low 9.5 × 106 ± 4.1 × 106 p = 0.009* 22,443 ± 18,977 p = 0.443
Medium 8.2 × 106 ± 2.8 × 106 1.4 × 106 ± 1.0 × 106
zp2 Control 2.8 × 106 ± 1.4 × 105 χ2 = 2.279, df = 2, 3.0 × 105 ± 74,376 χ2 = 2.920, df = 2,
Low 9.2 × 104 ± 3.0 × 104 p = 0.320 4.0 × 105 ± 132,414 p = 0.232
Medium 1.4 × 105 ± 3.7 × 104 1.9 × 105 ± 57,519
apo Control 2.4 × 105 ± 7.8 × 105 χ2 = 8.861, df = 2, 3.4 × 106 ± 7.3 × 105 χ2 = 0.608, df = 2,
Low 5.2 × 105 ± 1.1 × 105 p = 0.012* 2.7 × 106 ± 6.3 × 105 p = 0.997
Medium 6.5 × 105 ± 2.2 × 105 3.0 × 106 ± 9.4 × 105
nasp Control 527± 267 χ2 = 6.151, df = 2, 540 ± 178 χ2 = 0.106, df = 2,
Low 14,711 ± 9,459 p = 0.046* 3,079 ± 227 p = 0.948
Medium 21,351 ± 14,738 1,098 ± 494
*Signiﬁcant at p = 0.05.
Figure 3. Box plot of molecules of vitellogenin RNA
per nanogram of total RNA for female FHM treated
with three different MeHg-contaminated diets at 5%
body mass per day (10 ﬁsh per treatment); control,
0.058 ± 0.004 µg MeHg/g dry wt; low, 0.87 ± 0.02 µg
MeHg/g dry wt; medium, 3.93 ± 0.08 µg MeHg/g dry
wt. Data indicate suppressed vitellogenin RNA
expression with increasing MeHg exposure (χ2 =
10.835, df = 2, p = 0.004). Boxes represent the
interquartile range (first to third quartiles of data)
with the middle lines indicating the median and bars
indicating the range of data.
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with ROS (e.g., changes in the expression of
sod, gst) with MeHg exposure (these genes were
on the macroarray) at these levels of MeHg.
Instead, our array data indicated differential
expression associated with apoptosis, phospho-
lipid biosynthesis, sugar metabolism, interfer-
ence with gonadotropin pathways, calcium
regulation, phospholipid biosynthesis, and
plasma transport of proteins. This may be a
factor of dose, as Gonzalez et al. (2005) did
find evidence of differential expression of
ROS-related genes at much higher MeHg con-
centrations. Regardless, according to our data,
there is a clear separation between the effects of
oxidative stress and reproductive effects.
Differential gene expression in this study
does overlap with gene expression patterns
associated with known estrogenic compounds
(e.g., Larkin et al. 2003), which lends support
to the hypothesis of MeHg as a nonsteroidal
endocrine disruptor. Of the genes that dif-
fered among treatments, vitellogenin is of par-
ticular interest due to the recommendation of
assessment of vitellogenin in protocols for
screening potential endocrine-disrupting
chemicals (Endocrine Disruptor Screening
and Testing Advisory Committee 1998;
Marin and Motozzo 2004). This is due to its
sensitivity as a biomarker and the correlation
with adverse effects in male and female fish
(e.g., Panter et al. 1998). Vitellogenin is a
female-speciﬁc glucolipoprotein yolk precur-
sor produced by all oviparous animals and is
expressed specifically in the liver and trans-
ported to the gonad in females during egg
development. It is up-regulated before yolk
deposition and is important in egg produc-
tion. Although not normally produced by
male fish, its expression can be induced in
males by injection of 17β-estradiol or expo-
sure to chemicals that mimic estrogens (Byrne
et al. 1989; Tong et al. 2004). When pro-
duced in males, vitellogenin is not readily
removed from the bloodstream and can ulti-
mately cause kidney and liver damage (Elliot
et al. 1979; Herman and Kincaid 1988).
The presence of vitellogenin in some male
ﬁsh in this experiment provides an indication
that MeHg contamination may be causing an
estrogenic-like effect; however, results for
individual male fish were variable. Variable
vitellogenin responses of males has also been
found in other studies in which ﬁsh have been
exposed to known endocrine-disrupting com-
pounds in the field or laboratory (George
et al. 2004; Sole et al. 2002). In each of these
cases, of the total population sampled, up to
50% of ﬁsh express vitellogenin. Vitellogenin
in males in the present study never reached
the levels found in female ﬁsh.
In contrast, dietary MeHg significantly
suppressed vitellogenin gene expression in sex-
ually mature female ﬁsh (Figure 3), potentially
affecting egg production. This is the ﬁrst study
to measure differences in the gene expression
of vitellogenin and other genes associated with
reproduction in response to environmentally
realistic concentrations of MeHg. This was
also associated with a decline in estrogen as
well as a decline in reproduction (Drevnick
and Sandheinrich 2003). In another study,
Kirubagaran and Joy (1995) found that
MeHg exposure decreased phospholipid con-
tent in ovarian tissue of ﬁsh  and hypothesized
that this is due to inhibition of vitellogenin
synthesis in the liver. Vitellogenin gene expres-
sion declined in liver samples of ﬁsh exposed
to MeHg, which supports this hypothesis.
Additional genomic biomarkers associated
with endocrine disruption or reproduction
that changed with MeHg exposure include
genes responsible for proteins for egg fertiliza-
tion and implantation (zp2 and zp3), choles-
terol and lipid transport (apo), and cell
division (nasp). Expression of apo and nasp was
found to increase in females that had been
exposed to MeHg.
Apoptosis, variance in sugar metabolism,
and calcium regulation also appear linked to
MeHg exposure in this study. The enzyme
GAPDH is involved in glycolysis and is pro-
posed to play an important role in apoptosis
(Chuang et al. 2005). Hypoxia and diabetes
increase the expression of this enzyme in vari-
ous tissues (Beisswenger et al. 2003; Graven
and Farber 1995; Wentzel et al. 2003), and it
was up-regulated in female fish exposed to
MeHg. This may indicate a link between
changes in sugar metabolism and apoptosis in
liver tissue after MeHg exposure. However,
this change appeared to be female specific,
potentially indicating sex-specific effects of
MeHg on metabolism. Other genes associated
with sugar metabolism included glucose
6-phosphatase, involved in the production of
glucose, and α-amylase, an enzyme that con-
verts starches to sugars. Genes for 4-hydroxy-
phenylpyruvate dioxygenase, α-amylase, and
retinal binding protein were all up-regulated in
male ﬁsh, whereas glucose 6-phosphatase was
down-regulated with MeHg exposure. Because
these genes are associated with sugar metabo-
lism, insulin function, and diabetes in mam-
mals, our data indicate that MeHg may disrupt
these functions particularly in males, and there
may be a link between MeHg exposure and
certain metabolic diseases.
MeHg has been shown to affect bone
cells, inducing hypercalcemia in goldﬁsh and
disrupting calcium homeostasis (Suzuki et al.
2004). Calcium levels in the blood are related
to estrogen levels and affect the transport and
metabolism of proteins. Because many of the
differentially expressed genes identiﬁed in the
macroarray analysis are associated with cal-
cium, direct disruption of calcium transport
or alteration in the levels of calcium may be
responsible for some of these effects.
This study suggests that MeHg acts as an
endocrine disruptor and affects not only gene
expression associated with reproduction and
endocrine function but other pathways as
well. The genomic response to MeHg appears
different than the response of vertebrates to
other heavy metals. As more genomic data
become available for other heavy metals and
endocrine-disrupting compounds, continua-
tion of this work to evaluate unique gene
expression patterns will provide specific bio-
markers that indicate the impact of MeHg
versus that of other toxic compounds.
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